Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set

Affiliations

• ¹ Rheumatology Research Group, Basil Hetzel Institute, Adelaide, Australia, Adelaide Medical School, University of Adelaide, Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia, Rheumatology Unit, Lyell McEwin Hospital, Adelaide, Australia, Adelaide, Australia.
• ² Division of Rheumatology, University of Massachusetts Medical School, Worcester, Massachusetts, USA, Division of Rheumatology, UMass Memorial Health Care, Worcester, MA, USA.
• ³ Rheumatology Research Group, Basil Hetzel Institute, Adelaide, Australia, Adelaide Medical School, University of Adelaide, Adelaide, Australia, Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia, Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia.
• ⁴ Musculoskeletal Statistics Unit at The Parker Institute, Bispebjerg, Denmark, Frederiksberg Hospital, Copenhagen & Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Denmark.
• ⁵ Division of Rheumatology, Hospital for Special Surgery, New York, USA.
• ⁶ Patient research partner.
• ⁷ Rheumatology Research, Centre for Health and Clinical Research, University of the West of England, Bristol, UK, Rheumatology Department, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
• ⁸ Bruyère Research Institute, Senior Methodologist, Ottawa Hospital Research Institute, Ottawa, Canada, Adjunct Professor, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canada.
• ⁹ SDG, LLC, Cambridge, MA, USA.
• ¹⁰ Medicine Service, VA Medical Center, 700 19th St S, Birmingham, AL 35233 USA, Department of Medicine at the School of Medicine, University of Alabama at Birmingham (UAB), 1720 Second Ave. South, Birmingham, AL 35294-0022, USA, Department of Epidemiology at the UAB School of Public Health, 1665 University Blvd., Ryals Public Health Building, Room 220, Birmingham, AL, 35294-0022, USA.
• ¹¹ Division of Rheumatology, Department of Medicine, University of Ottawa, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Abbreviation.
• ¹² Department of Epidemiology & Data Science, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands, Marco A Alba Garibay, Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, IRB-CELLEX, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.
• ¹³ Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, IRB-CELLEX, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.
• ¹⁴ Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
• ¹⁵ Patient-Oriented Rehabilitation Lab (SPOR-REHAB), University of Sherbrooke, Faculty of Medicine and Health Sciences, School of Rehabilitation, Research Centre of the CHUS, CIUSSS de l'Estrie-CHUS, Canada.
• ¹⁶ Department of Dermatology & Department of Pathology Cleveland Clinic, Cleveland, OH, USA.
• ¹⁷ School of Medicine, University of Western Australia, Perth, Australia, Rheumatology Department, Fiona Stanley Hospital, Perth, Australia.
• ¹⁸ Department of Medicine, University of Toronto, Canada.
• ¹⁹ Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
• ²⁰ North-Western State medical University named after II Mechnikov, Saint-Petersburg, Russia.
• ²¹ University of Pennsylvania, Division of Rheumatology, Philadelphia, PA, USA.
• ²² Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow India.
• ²³ Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, College of Medicine and Public Health, Flinders University, Adelaide, South Australia.
• ²⁴ Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
• ²⁵ Rheumatologist, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK.
• ²⁶ Rheumatology department, Royal North Shore Hospital, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, University of Medicine, Mandalay, Mandalay, Myanmar.
• ²⁷ Division of Rheumatology, Johns Hopkins University School of Medicine, USA.
• ²⁸ Discipline of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, South Australia, Australia, Rheumatology Research Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.
• ²⁹ Adelaide Medical School, The University of Adelaide, Adelaide, South Australia.
• ³⁰ Serviço de Reumatologia, Hospital de Faro, Centro Hospitalar Universitário do Algarve, Portugal.
• ³¹ School of Rehabilitation Sciences, Faculty of Health Sciences, University of Ottawa, Department of Pediatrics, Faculty of Medicine, University of Ottawa, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada.
• ³² Department of Medicine, University of Jos, Nigeria.
• ³³ Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
• ³⁴ Division of Rheumatology, Hospital for Special Surgery, New York, USA, Weill Cornell Medical College, New York, USA.
• ³⁵ Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia, Rheumatology Research Group, Basil Hetzel Institute, Adelaide, Australia, Adelaide Medical School, University of Adelaide, Adelaide, Australia. Electronic address: catherine.hill@sa.gov.au.